The Birtwistle Lab combines computational and experimental methods to understand how cancer cells make decisions. We aim to use this understanding to better predict drug and drug combination responses. We give particular focus to brain tumors, although the approaches we take are quite flexible and can be applied to a multitude of cell and cancer types. Our goal is to build simulation models that can guide patient-specific therapies by accounting for mechanisms of drug action within the unique complexity of an individual’s tumor. This goal brings with it both basic and applied science projects.

See our Research and Publications page for more detailed information. We are very thankful for current funding from the National Institutes of Health (NIGMS, NHGRI and NCI), Roche, and Glaxo-Smith-Kline

Keep up with what's going on in the lab via our Twitter feed: